SWK Holdings Corp 8-K, filed Jan 23, 2020
SWK Holdings Corp (SWKHL)
About this 8-K
SWK Holdings Corp filed this 8-K on January 23, 2020.
Items reported
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 23, 2020
SWK HOLDINGS CORPORATION
(Exact Name of the Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
|
000-27163 |
77-0435679 |
|
(Commission File Number) |
(IRS Employer Identification No.) |
|
14755 Preston Road, Suite 105, Dallas, TX |
75254 |
|
(Address of Principal Executive Offices) |
(Zip Code) |
(972) 687-7250
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On January 23, 2020, the Company issued a press release announcing that its shares of common stock commenced trading on the Nasdaq Capital Market effective January 23, 2020 under the ticker symbol “SWKH.”
| Item 9.01 | Financial Statements and Exhibits. |
| Exhibit No. | Description |
| 99.1 |
Press Release of SWK Holdings Corporation, dated January 23, 2020 Announcing Commencement of Trading on the Nasdaq Capital Market
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
SWK HOLDINGS CORPORATION |
||
|
By: |
/s/ WINSTON BLACK |
|
|
Winston Black |
||
|
Chief Executive Officer |
||
Date: January 23, 2020
EXHIBIT INDEX
| Exhibit No. |
Description
|
| 99.1 | Press Release of SWK Holdings Corporation, dated January 23, 2020 Announcing Commencement of Trading on the Nasdaq Capital Market |
Exhibit 99.1

SWK Holdings Corporation Announces Commencement of Trading on the Nasdaq Capital Market
Trading begins today, January 23, 2020, under the ticker symbol “SWKH”
SWK Holdings to ring the Nasdaq Stock Market Opening Bell
Dallas, TX, January 23, 2020 – SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its shares of common stock will begin trading on the Nasdaq Capital Market beginning today at 9:30 a.m., EST under the ticker symbol “SWKH.”
Additionally, this morning, Chairman and Chief Executive Officer Winston Black and other members of SWK’s management team will ring the Nasdaq Opening Bell. The Opening Bell ceremony will be broadcast live starting at 9:15 a.m., EST from the Nasdaq MarketSite Tower in New York City. To view the broadcast, please visit: https://www.nasdaq.com/marketsite/bell-ringing-ceremony.
About SWK Holdings Corporation
SWK Holdings Corporation is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK’s business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. Additional information on the life science finance market is available on the Company’s website at www.swkhold.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plan,” “will,” “may,” “look forward,” “intend,” “guidance,” “future” or similar expressions are forward-looking statements. Because these statements reflect SWK’s current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption “Risk Factors” and elsewhere in SWK’s Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company’s future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company’s actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
Investor / Media Relations:
Maureen McEnroe / Jason Rando
Tiberend Strategic Advisors, Inc.
212.375.2664 / 212.375.2665
mmcenroe@tiberend.com / jrando@tiberend.com